UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Learn why financial indices are useful benchmarks, guide portfolio decisions, and help you compare performance across assets.
24,895 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Analysts lift HIMS, TDOC, and ALEC as strategic partnerships reduce key risks, prompting renewed upside potential and...
Barclays lifts ratings on Arthur J. Gallagher and Willis Towers Watson, contending that disruption fears overdone, sa...
McDonald’s unveils a $3 meal, intensifying the battle for America’s cheapest menu. Investors weigh margin risk as val...
Exxon Mobil, Chevron and other producers climb to all-time stock valuations as geopolitical risk pushes energy prices...
SanDisk shares jumped about 6% on Friday as a persistent NAND shortage supports higher prices and prolonged demand fr...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...
Playnance rolled out GCOIN staking on PlayW3, locking 250 million tokens in hours and tying rewards to ecosystem acti...
Real estate teams can close VA loans faster by aligning lenders, agents, and veterans. This piece offers practical gu...
BlackRock CEO Larry Fink warns that AI disruption could raise unemployment among new graduates, even in a steady econ...
Microsoft kicks off 2026 with a rough start as earnings beat clashes with a surge in capital expenditures. Traders de...
XRP continues to slide in March 2026 despite regulatory wins and Brazil expansion, with traders weighing macro risks,...